RSS-Feed abonnieren
DOI: 10.1055/s-2003-42399
A Facile Synthesis of a Key Intermediate for (+)-Biotin via Strecker Reaction
Publikationsverlauf
Publikationsdatum:
29. September 2003 (online)
Abstract
The Strecker reaction of (2R,4R)-2-phenyl-3-phenoxycarbonylthiazolidine-4-carbaldehyde (4b), which was readily prepared from l-cysteine, with benzylamine and trimethylsilyl cyanide provided α-amino nitrile 5b stereoselectively (syn-anti, 2:1). Amidation of 5b and subsequent cyclization gave bicyclic compound 6, which, upon reduction with zinc dust, hydrolysis and subsequent cyclization, furnished thiolactone 2, a key intermediate for (+)-biotin (1).
Keywords
amino acids - amino aldehydes - ring closure - stereoselectivity - vitamins - biotin - Strecker reaction
- 1a 
             
            
Mistry PS.Dakshinamurti K. Vitam. Horm. 1964, 22: 1 - 1b 
             
            
Coggeshall CJ.Heggers PJ.Robson CM.Baker H. Ann. N. Y. Acad. Sci. 1985, 447: 389 - 1c 
             
            
Maebashi M.Makino Y.Furukawa Y.Ohinata K.Kimura S.Sato T. J. Clin. Biochem. Nutr. 1993, 14: 211 - 2 For a review, see:  
            
De Clercq PJ. Chem. Rev. 1997, 97: 1755 - 3a  
            
Goldberg MW, andSternbach LH. inventors; US Patent 2489232. ; Chem. Abstr. 1951, 45, 184b - 3b  
            
Goldberg MW, andSternbach LH. inventors; US Patent 248923. ; Chem. Abstr. 1951, 45, 186a - 3c 
             
            
Gerecke M.Zimmermann J.-P.Ashwanden W. Helv. Chim. Acta 1970, 53: 991 - For example, see:
 - 4a 
             
            
Senuma M.Fujii T.Seto M.Okamura K.Date T.Kinumaki A. Chem. Pharm. Bull. 1990, 38: 882 - 4b 
             
            
Iriuchijima S.Hasegawa K.Tsuchihashi G. Agric. Biol. Chem. 1982, 46: 1907 - 4c 
             
            
Matsuki K.Inoue H.Takeda M. Tetrahedron Lett. 1993, 34: 1167 - 4d 
             
            
Chen FE.Huang Y.-D.Fu H.Cheng Y.Zhang D.-M.Li Y.-Y.Peng Z.-Z. Synthesis 2000, 2004 - 4e 
             
            
Choi C.Tian S.-K.Deng L. Synthesis 2001, 1737 - 4f 
             
            
Seki M.Shimizu T.Inubushi K. Synthesis 2002, 361 - 5 
             
            
Poetsch E.Casutt M. Chimia 1987, 41: 148 - 6a 
             
            
Seki M.Hatsuda M.Mori Y.Yamada S. Tetrahedron Lett. 2002, 43: 3269 - 6b 
             
            
Seki M.Mori Y.Hatsuda M.Yamada S. J. Org. Chem. 2002, 67: 5527 - 7a 
             
            
Doering WVE.Parikh JR. J. Am. Chem. Soc. 1967, 89: 5505 - 7b 
             
            
Hamada Y.Shioiri T. Chem. Pharm. Bull. 1982, 30: 1921 - 9 
             
            
Seebach D.Sting AR.Hoffmann M. Angew. Chem. Int. Ed. Engl. 1996, 35: 2708 - 10 
             
            
Kobayashi S.Tsuchiya Y.Mukaiyama T. Chem. Lett. 1991, 537 - 11 
             
            
Katritzky AR.Pilarski B.Urogdi L. Synthesis 1989, 949 - 12a 
             
            
Shimizu T.Seki M. Tetrahedron Lett. 2000, 41: 5099 - 12b 
             
            
Shimizu T.Seki M. Tetrahedron Lett. 2001, 42: 429 - 12c 
             
            
Shimizu T.Seki M. Tetrahedron Lett. 2002, 43: 1039 - 12d 
             
            
Mori Y.Seki M. Heterocycles 2002, 58: 125 
References
The X-ray data of syn-5a have been deposited at the Cambridge Crystallographic Data Centre.
13Poetsch and Casutt of the Merck Laboratories synthesized the bicyclic intermediate
         14 through reduction of a carbonyl group of bicyclic hydantoin 13 derived from l-cysteine followed by formation of the corresponding imidazolide, cyanation and hydrolysis
         (Scheme 
         [6]
         ).
         [5]
          
Although the approach can provide 2 in 9 steps, it requires expensive or hazardous reagents such as BnNCO and CDI.